Intrua Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $867K | Sell |
18,738
-3,878
| -17% | -$180K | 0.12% | 130 |
|
|
2025
Q1 | $1.38M | Buy |
22,616
+4,652
| +26% | +$284K | 0.2% | 85 |
|
|
2024
Q4 | $1.02M | Sell |
17,964
-356
| -2% | -$20.1K | 0.16% | 106 |
|
|
2024
Q3 | $948K | Sell |
18,320
-1,597
| -8% | -$82.6K | 0.14% | 126 |
|
|
2024
Q2 | $827K | Buy |
19,917
+4,315
| +28% | +$179K | 0.12% | 144 |
|
|
2024
Q1 | $846K | Buy |
15,602
+4,522
| +41% | +$245K | 0.12% | 156 |
|
|
2023
Q4 | $569K | Buy |
11,080
+2,677
| +32% | +$137K | 0.08% | 203 |
|
|
2023
Q3 | $488K | Buy |
8,403
+819
| +11% | +$47.5K | 0.08% | 197 |
|
|
2023
Q2 | $485K | Buy |
7,584
+2,124
| +39% | +$136K | 0.08% | 200 |
|
|
2023
Q1 | $372K | Buy |
5,460
+865
| +19% | +$58.9K | 0.08% | 218 |
|
|
2022
Q4 | $339K | Sell |
4,595
-753
| -14% | -$55.5K | 0.08% | 234 |
|
|
2022
Q3 | $380K | Sell |
5,348
-692
| -11% | -$49.2K | 0.1% | 199 |
|
|
2022
Q2 | $465K | Sell |
6,040
-2,692
| -31% | -$207K | 0.1% | 216 |
|
|
2022
Q1 | $638K | Sell |
8,732
-1,346
| -13% | -$98.3K | 0.11% | 187 |
|
|
2021
Q4 | $628K | Buy |
10,078
+723
| +8% | +$45.1K | 0.11% | 184 |
|
|
2021
Q3 | $528K | Buy |
+9,355
| New | +$528K | 0.1% | 202 |
|
|
2021
Q2 | – | Sell |
-3,226
| Closed | -$213K | – | 296 |
|
|
2021
Q1 | $213K | Buy |
+3,226
| New | +$213K | 0.05% | 273 |
|